Life Sciences Drug DevelopmentBoston, MA
Centrexion Therapeutics is transforming the treatment of chronic pain by advancing one of the largest exclusively pain-focused pipelines of novel, non-opioid therapies. We are working to bridge the safety and efficacy gaps in current approaches to chronic pain management. Chronic pain is a growing problem, not only in terms of the significant number of people that are impacted and the burden this places on our healthcare system, but also because of the abuse and addiction issues, as well as deaths, that have arisen from the high use of opioids to treat chronic pain.
Our mission is to relieve the suffering associated with chronic pain by developing treatments that address the safety and efficacy gaps in the current treatment paradigm. Our broad pipeline represents our mission to attack the problem of chronic pain in many different ways, including a topical gel, a deeper tissue injection, a spinal delivery, and three separate oral treatments.
We believe that our non-opioid approach to chronic pain treatment has the potential to provide effective therapeutic options while avoiding the abuse and addiction epidemic that has resulted from high use of opioid drugs.